We hypothesize that the effect of HIV-1 protease inhibitor on IL-1β levels in the treatment of insulinoma may be achieved through the NF-κB signaling pathway, but the present study did not conduct cell experiments to verify this, requiring in-depth analysis in our future research. The gene discussed is NFKB1; the disease is pancreatic insulinoma.